These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 5526985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Some epidemiological aspects of the prevention of Rh isoimmunization.
    Walker W.
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):431-5. PubMed ID: 5003520
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The future of Rh immune globulin.
    Gorman JG.
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):422-6. PubMed ID: 5003518
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG, Meriggi E, De Martin G.
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract] [Full Text] [Related]

  • 7. Different doses of anti-Rh IgG in relation to transplacental haemorrhage.
    Curiel P, Mello G, Carapella E, Gerlini G, Galati G, Massi GB.
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):455-6. PubMed ID: 5535694
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Severe neonatal jaundice: Fetal management in hematologically incompatible pregnancy].
    Jinbo T, Sato T.
    Kango Gijutsu; 1975 Feb; 21(2):100-12. PubMed ID: 803599
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of Rh prophylaxis.
    Woodrow JC.
    Haematologia (Budap); 1974 Feb; 8(1-4):281-90. PubMed ID: 4218822
    [No Abstract] [Full Text] [Related]

  • 12. Current problems in prophylactic treatment of Rh-erythroblastosis.
    J Reprod Med; 1971 May; 6(5):232-55. PubMed ID: 4937675
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Problems in anti-rhesus (D) immunoprophylaxis].
    Bennebroek Gravenhorst J, Overbeeke MA, van Dijk BA.
    Ned Tijdschr Geneeskd; 1984 May 26; 128(21):1005-9. PubMed ID: 6429554
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
    Mills L, Napier JA.
    Br J Obstet Gynaecol; 1988 Oct 26; 95(10):1007-12. PubMed ID: 2847774
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention of feto-maternal Rh isoimmunization].
    Gómez Piña de la Peza, Lamadrid Montemayor F, Flores Rodríguez JJ.
    Ginecol Obstet Mex; 1971 Jan 26; 29(171):99-104. PubMed ID: 4996660
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.